
<DOC>
<DOCNO>
WSJ900622-0035
</DOCNO>
<DOCID>
900622-0035.
</DOCID>
<HL>
   Business Brief -- Diagnostek Inc.:
   Drug Firm Reaches Accord
   To Buy Epic Health Group
</HL>
<DATE>
06/22/90
</DATE>
<SO>
WALL STREET JOURNAL (J), NO PAGE CITATION
</SO>
<CO>
   DXTK EPIC
</CO>
<IN>
TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)
</IN>
<LP>
   Diagnostek Inc. executed a definitive agreement to acquire
Epic Health Group Inc. for $13.5 million, the companies said.
   They said the price works out to $1.04 a common share and
$7.70 a preferred share. To start the acquisition, a
Diagnostic subsidiary said it would soon begin a tender offer
for Epic shares.
</LP>
<TEXT>
   However, Epic said the prices are subject to reduction
under certain circumstances, on the basis of its performance
during a 30-day period of the tender offer.
   Diagnostek, based in Albuquerque, N. M., provides drug
cost-control programs, including programs to sell drugs by
mail, and pharmacy-management services. Epic, based in
Elmsford, N.Y., provides mail-order prescription-drug
programs.
   Epic closed at 81.25 cents, up 18.75 cents, in
over-the-counter trading. Diagnostek closed at $16.25, up
37.5 cents, in national over-the-counter trading.
</TEXT>
</DOC>